{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:22:59Z","timestamp":1779146579527,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.adro.2022.101019","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:31:47Z","timestamp":1658197907000},"page":"101019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Brien","family":"Washington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Cheek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2022.101019_bib0001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2022.101019_bib0002","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1088\/0026-1394\/49\/5\/S253","article-title":"Overview on the dosimetric uncertainty analysis for photon-emitting brachytherapy sources","volume":"49","author":"DeWerd","year":"2012","journal-title":"Metrologia"},{"key":"10.1016\/j.adro.2022.101019_bib0003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1118\/1.3533720","article-title":"A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO","volume":"38","author":"DeWerd","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2022.101019_bib0004","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/acm2.12462","article-title":"Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer","volume":"19","author":"Liu","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2022.101019_bib0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brachy.2013.08.010","article-title":"Impact of delineation uncertainties on dose to organs at risk in CT-guided intracavitary brachytherapy","volume":"13","author":"Duane","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2012.12.017","article-title":"Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy","volume":"107","author":"Hellebust","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0007","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brachy.2020.01.002","article-title":"Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer","volume":"19","author":"Bell","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-8140(00)00185-7","article-title":"Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer","volume":"56","author":"Saarnak","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0009","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.radonc.2014.11.016","article-title":"Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy","volume":"113","author":"Arnesen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2013.01.014","article-title":"Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study","volume":"107","author":"Petri\u010d","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brachy.2015.11.004","article-title":"Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?","volume":"15","author":"Patel","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.radonc.2015.08.017","article-title":"Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy","volume":"117","author":"Kobayashi","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brachy.2014.11.014","article-title":"Intrafractional organs movement in three-dimensional image-guided adaptive pulsed-dose-rate cervical cancer brachytherapy: Assessment and dosimetric impact","volume":"14","author":"Mazeron","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2013.01.013","article-title":"Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy","volume":"107","author":"Andersen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2013.02.014","article-title":"Uncertainties in image guided adaptive cervix cancer brachytherapy: Impact on planning and prescription","volume":"107","author":"Tanderup","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0016","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2016.06.008","article-title":"Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome?","volume":"120","author":"Nesvacil","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0017","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.brachy.2017.10.002","article-title":"Dose warping uncertainties for the accumulated rectal wall dose in cervical cancer brachytherapy","volume":"17","author":"van Heerden","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0018","article-title":"Magnitude and implications of interfraction variations in organ doses during high dose rate brachytherapy of cervix cancer: A CT-based planning study","volume":"2014","author":"Chakraborty","year":"2014","journal-title":"ISRN Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.radonc.2013.01.011","article-title":"Inter-application variation of dose and spatial location of D(2cm(3)) volumes of OARs during MR image based cervix brachytherapy","volume":"107","author":"Jamema","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.101019_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5114\/jcb.2011.21039","article-title":"Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer: A prospective study","volume":"3","author":"Sharma","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brachy.2020.07.009","article-title":"A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma","volume":"20","author":"Mourya","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0022","article-title":"Prescribing, recording, and reporting brachytherapy for cancer of the cervix","volume":"13","year":"2013","journal-title":"J ICRU"},{"key":"10.1016\/j.adro.2022.101019_bib0023","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00031305.1993.10475992","article-title":"How to approximate a histogram by a normal density","volume":"47","author":"Brown","year":"1993","journal-title":"Am Stat"},{"key":"10.1016\/j.adro.2022.101019_bib0024","first-page":"1","article-title":"Comparing distributions: the two-sample Anderson-Darling test as an alternative to the Kolmogorov-Smirnoff test","volume":"6","author":"Engmann","year":"2011","journal-title":"JAQM"},{"key":"10.1016\/j.adro.2022.101019_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.101019_bib0026","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2008.06.010","article-title":"Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer","volume":"89","author":"Tanderup","year":"2008","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.adro.2022.101019_bib0027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jrr\/rrz016","article-title":"Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience","volume":"60","author":"Kashihara","year":"2019","journal-title":"J Radiat Res"},{"issue":"2","key":"10.1016\/j.adro.2022.101019_bib0028","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2019.11.004","article-title":"Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies","volume":"19","author":"Murakami","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society Cervical Cancer Recommendations Committee, American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.adro.2022.101019_bib0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2013.11.002","article-title":"Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM","volume":"110","author":"Kirisits","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:41:53Z","timestamp":1762530113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109422001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2452109422001257"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2022.101019","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2022.101019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101019"}}